Vascular complications and gene therapy

S Roy, JG Rothschild, A Chen - Expert Opinion on Biological …, 2003 - Taylor & Francis
For gene therapy, the last few years have been an exciting period. Encouraging results from
several successful gene therapy trials were reported. Children born with a life-threatening …

[引用][C] The Journal of Gene Medicine Japanese Society of Gene Therapy Young Investigator Award 2003

K Egashira - Journal of Gene Medicine, 2005 - search.proquest.com
Background: Drug-eluting stents (DES) have proven to be useful to prevent restenosis.
These ''first-generation''DES, however, have serious problems of delayed healing process …

[引用][C] Rep. Eshoo Proposes Trust Fund For Biomedical Research

A Busch - Inside CMS, 2014 - JSTOR

[引用][C] 805-4 Biodegradable scaffolds incorporating vascular endothelial growth factor as a novel sustained delivery platform to induce angiogenesis

Q Sun, R Chen, DJ Mooney, S Rajagopalan… - Journal of the American …, 2004 - jacc.org
Background: Therapeutic angiogenesis strategies have focused on protracted delivery of
growth factors using gene transfer approaches that are limited by potential toxicitiy and …

Applied gene therapy in preclinical models of vascular injury

SP Janssens - Current atherosclerosis reports, 2003 - Springer
Atherosclerosis remains the major cause of morbidity and mortality in Western countries.
Atherothrombotic complications, including vascular occlusions and severe narrowing of …

[PDF][PDF] Hydrodynamic Gene Delivery of CC Chemokine Binding Fc Fusion proteins to target Acute Vascular Inflammation In Vivo

KM Channon - academia.edu
Materials and Methods Materials. All cell culture media and buffers were obtained from
Invitrogen (UK) unless otherwise specified. All laboratory chemicals were from Sigma …

Gene Therapy Approaches with iNOS Edith Tzeng and Timothy R. Billiar

GM Rubanyi - Pathophysiology and Clinical Applications of Nitric …, 1999 - taylorfrancis.com
The arterial wall is composed of the intima, media, and adventitia. The intima consists of the
endothelium and, in some species, 1-2 layers of SMCs as well (Schwartz et al., 1995a) …

Epidermal growth factor receptor–targeted cytotoxin inhibits neointimal hyperplasia in vivo: results of local versus systemic administration

CJ Pastore, JM Isner, PA Bacha, M Kearney… - Circulation …, 1995 - Am Heart Assoc
Smooth muscle cell accumulation is a key feature of restenosis that may be inhibited by the
delivery of receptor-targeted cytotoxins. DAB389EGF is a recombinant fusion protein in …

[PDF][PDF] Therapeutic Angiogenesis

AP Phase - Circ Res, 2006 - Citeseer
Efforts to stimulate tissue vascularization in patients with ischemia resulting from coronary or
peripheral arterial disease (therapeutic angiogenesis1, 2) have passed through several …

[PDF][PDF] Let us know how access to this document benefits you.

SP Persengiev - 1999 - core.ac.uk
MATERIALS AND METHODS Cell cultures. PC12 cells were grown on collagen-coated
plates in Dulbecco's modified Eagle medium (DMEM) with or without 10% horse serum–5 …